A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Carfilzomib Impurity 110 - Request Quote

Picture of Carfilzomib Impurity 110

Carfilzomib Impurity 110

SZ CAT No:SZ-C070130
CAS No
NA
Mol.F.
C14H18N2O5
Mol.Wt.
294.3
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Carfilzomib Impurity 110 is chemically (S)-3-amino-4-(((S)-1-carboxy-3-phenylpropyl)amino)-4-oxobutanoic acid. Carfilzomib Impurity 110 is supplied with detailed characterization data compliant with regulatory guideline. Carfilzomib Impurity 110 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Carfilzomib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Carfilzomib Impurity 110

Purchase Carfilzomib Impurity 110

Carfilzomib Impurity 110 suppliers

Carfilzomib Impurity 110 manufacturers

Carfilzomib Impurity 110 price

Order Carfilzomib Impurity 110

Enquire Carfilzomib Impurity 110

Carfilzomib Impurity 110 cost

Carfilzomib Impurity 110 Supplier

Carfilzomib Impurity 110 Distributor

Carfilzomib Impurity 110 for Method Validation

Carfilzomib Reference Standard

Carfilzomib Impurity 110 for ANDA Filing

Carfilzomib Impurity 110 for Forced Degradation Studies

Carfilzomib Impurity 110 Identification Standards

Carfilzomib Impurity 110 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,